Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Cottin

Showing results (291-300 of 468) with videos related to

Pageof 47
Sort By:
The European Respiratory Journal|April 25, 2024
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertensionAthénaïs Boucly, Antoine Beurnier, Ségolène Turquier, et al.
The European Respiratory Journal|December 25, 2014
Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertensionPierre-Yves Courand, Géraldine Pina Jomir, Chahéra Khouatra, et al.
Chest|November 21, 2024
Association of Pulmonary Hypertension With Trastuzumab Emtansine: An Analysis of French Pulmonary Hypertension Registry and WHO Pharmacovigilance DatabaseCamille Poisson, Alex Hlavaty, Nicolas Favrolt, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 27, 2021
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?Meena Kalluri, Fabrizio Luppi, Ada Vancheri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitisDominique Arpin, David Perol, Jean-Yves Blay, et al.
Orphanet Journal of Rare Diseases|December 5, 2016
Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohortYves Pacheco, Alain Calender, Dominique Israël-Biet, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b studySteven D Nathan, Jürgen Behr, Harold R Collard, et al.
The European Respiratory Journal|September 21, 2019
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell diseaseLaurent Savale, Anoosha Habibi, François Lionnet, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
Plos One|May 16, 2018
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosisDavid Launay, David Montani, Paul M Hassoun, et al.
Pageof 47

Showing results (291-300 of 468) with videos related to

Sort By:
Pageof 47
The European Respiratory Journal|April 25, 2024
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertensionAthénaïs Boucly, Antoine Beurnier, Ségolène Turquier, et al.
The European Respiratory Journal|December 25, 2014
Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertensionPierre-Yves Courand, Géraldine Pina Jomir, Chahéra Khouatra, et al.
Chest|November 21, 2024
Association of Pulmonary Hypertension With Trastuzumab Emtansine: An Analysis of French Pulmonary Hypertension Registry and WHO Pharmacovigilance DatabaseCamille Poisson, Alex Hlavaty, Nicolas Favrolt, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 27, 2021
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?Meena Kalluri, Fabrizio Luppi, Ada Vancheri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitisDominique Arpin, David Perol, Jean-Yves Blay, et al.
Orphanet Journal of Rare Diseases|December 5, 2016
Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohortYves Pacheco, Alain Calender, Dominique Israël-Biet, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b studySteven D Nathan, Jürgen Behr, Harold R Collard, et al.
The European Respiratory Journal|September 21, 2019
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell diseaseLaurent Savale, Anoosha Habibi, François Lionnet, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
Plos One|May 16, 2018
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosisDavid Launay, David Montani, Paul M Hassoun, et al.
Pageof 47